Navigation Links
American Journal of Infection Control Study Validates ATP Testing for Monitoring Sanitation in Hospitals; Charm Sciences Test Verified

Lawrence, MA (PRWEB) December 13, 2012

A study(1) published in the American Journal of Infection Control validated that ATP testing is an effective tool for monitoring the cleanliness of hospital surfaces. ATP (adenosine triphosphate) detection systems measure the amount of organic materials in a sample, such as blood, mucus, bacteria, and viruses. When used to verify the cleanliness of hospital surfaces, ATP testing results indicate whether a surface needs to be re-cleaned or cleaning methods need to be changed.

The study concludes that ATP testing is effective in monitoring sanitation in hospitals. ATP is stable over a ten-day period, unperturbed by sanitizer, and is removed with effective cleaning.

In the study, hospital surfaces were treated with three representative bacteria and blood as biological sources of ATP. Three different ATP detection systems, Hygiena SystemSURE II™ with Ultrasnap™ swab, 3M Clean-Trace™ NG with UXC swab, and Charm Sciences novaLUM® with PocketSwab® Plus swab, were evaluated and compared.

Some of the study criteria used were the linearity of ATP detection, limit of detection, lack of interference from other substances, swabbing efficiency, clinical sensitivity, reportable range, measure of cleanliness after cleaning, and test variability. Of the three tests, only the Charm Sciences novaLUM and PocketSwab Plus system was verified for use in hospitals without protocol modification.

[1] Carmen V. Sciortino PhD, R. Allen Giles BS. Validation and comparison of three adenosine triphosphate luminometers for monitoring hospital surface sanitization: A Rosetta Stone for adenosine triphosphate testing. American Journal of Infection Control . October 2012. 40(08) e233-9.

About Charm Sciences, Inc.
Charm Sciences is a world leader provider of food safety, water quality and environmental diagnostics. Charm’s diagnostics portfolio includes test kits and systems for antibiotics, mycotoxins, pesticides, alkaline phosphatase, pathogens, end product microbial assessment, allergen control, water quality and ATP hygiene. Directly and through its network of distributors, Charm products serve the food, beverage, water, pharmaceutical, medical, personal care, environmental, and industrial markets in more than 100 countries. Customers rely on Charm products for excellence in quality, innovation and customer support.

© 2012 Charm, novaLUM and PocketSwab are registered trademarks of Charm Sciences, Inc. SystemSURE II is a registered trademark of Hygiena LLC, Camarillo, CA, Clean-Trace is a registered trademark of 3M Company St. Paul, MN.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Analysis of Venture Capital Investment Trends in the North American and European Healthcare Industry
2. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
3. Data Presented at American Society of Hematology from Ibrutinib Phase 1b/2 and Phase 2 Trials Suggest High and Durable Response in Chronic Lymphocytic Leukemia
4. Amgen Highlights Data To Be Presented At American Society of Hematology Annual Meeting
5. Quest Diagnostics Clinical Trials Biorepository Accredited by the College of American Pathologists
6. The American College of Obstetricians and Gynecologists Committee on Genetics and the Society for Maternal-Fetal Medicine Publications Committee Recommend Noninvasive Prenatal Testing for Fetal Aneuploidy
7. Karyopharm Therapeutics Announces Oral Presentation at the American College of Rheumatology (ACR) on the use of Selective Inhibitors of Nuclear Export (SINE) CRM1 Antagonists in preclinical models of Systemic Lupus Erythematosus (SLE)
8. Astellas and Ambit Announce Data Presentations Highlighting Quizartinib at the American Society of Hematology 54th Annual Meeting
9. GDS International Confirms the Attendance of Top Executives to its Eleventh North American Healthcare Summit in December
10. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
11. GeneTex, Inc. to Attend the 2012 Annual Meeting of the American Society for Cell Biology
Post Your Comments:
(Date:11/25/2015)... 2015 Studies reveal the differences ... and pave the way for more effective treatment for one ...   --> --> ... problems in cats, yet relatively little was understood about the ... have been conducted by researchers from the WALTHAM Centre for ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
(Date:11/25/2015)... IN (PRWEB) , ... November 25, 2015 , ... ... (AMA) and the Organization of Black Aerospace Professionals (OPBAP) has been formalized with ... and other AMA team leaders met with OPBAP leaders Capt. Karl Minter and ...
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
Breaking Biology Technology:
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced expansion of its TDDI ... touch controller and display driver integration (TDDI) ... smartphones. These new TDDI products add to the ... resolution), TD4302 (WQHD resolution), and TD4322 (FHD resolution) ...
(Date:11/10/2015)... 2015  In this report, the biomarkers ... product, type, application, disease indication, and geography. ... are consumables, services, software. The type segments ... efficacy biomarkers, and validation biomarkers. The applications ... development, drug discovery and development, personalized medicine, ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
Breaking Biology News(10 mins):